Abstract
In the air pouch-type allergic inflammation in rats, we reported that a sustained histamine production in the late phase is induced by a cytokine-like factor, named histamine-production-increasing factor (HPIF) (1). Recently, we found another type of histamine-production-increasing factor in the pouch fluid at the chronic phase of air pouch-type allergic inflammation. Although it did not increase histamine production by itself, it enhanced the HPIF-induced histamine production by rat bone marrow cells. It also increased GM-CSF-induced histamine production. The activity of this factor increased time-dependently from 3 to 7 days after the antigen challenge. Injection of the 5 day pouch fluid sample containing this factor into the pouch 4 h after the antigen challenge increased histamine contents in the pouch fluid at 24 h, indicating that this factor enhances HPIF-induced histamine production in vivo. Biochemical analysis of the 5 day pouch fluid sample indicated that this factor is a heat-labile and trypsin-sensitive protein of which pI value and molecular weight are 7–8 and about 100 kDa, respectively.
Similar content being viewed by others
REFERENCES
Hirasawa, N., K. Ohuchi, K. Kawarasaki, M. Watanabe, and S. Tsurufuji. 1989. Occurrence of histamine-production-increasing factor in the post-anaphylactic phase of allergic inflammation. Int. Arch. Allergy Appl. Immunol. 88:386–393.
Endo, Y. 1982. Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Eschrichia Coli lipopolysaccharide into mice. Biochem. Pharmacol. 31:1643–1647.
Kawaguchi-Nagata, K., T.s Watanabe, A. Yamatodani, M. Inoue, J. Fujita, H. Okamura, T. Tamura, K. Shouji, H. Wada, and Y. Kitamura. 1987. Induction of histidine decarboxylase in non-mast cells in the spleen of mice by injection of Staphylococcal Enterotoxin A. J. Biochem. 102:551–557.
Endo, Y., and M. Nakamura. 1993. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol. 24:1039–1053.
Beaven, M. A., and H. Metzger. 1993. Signal transduction by Fc receptors: the FcεRI case. Immunol. Today 14:222–226.
Dy, M., and B. Lebel. 1983. Skin allografts generate an enhanced production of histamine and histamine-producing cell-stimulating factor (HCSF) by spleen cells in response to T cell mitogens. J. Immunol. 130:2343–2347.
Schneider, E., H. Pollard, F. Lepault, D. Guy-Grand, M. Minkowski, and M. Dy. 1987. Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells. J. Immunol. 139:3710–3717.
Dy, M., F. Machavoine, B. Lebel, A. Ichikawa, L. N. Gastinel, and E. Schneider. 1993. Interleukin 3 promotes histamine synthesis in hematopoietic progenitors by increasing histidine decarboxylase mRNA expression. Biochem. Biophys. Res. Commun. 192:167–173.
Endo, Y., T. Kikuchi, Y. Takeda, Y. Nitta, H. Rikiishi, and K. Kumagai. 1992. GM-CSF and G-CSF stimulate the synthesis of histamine and putrescine in the hematopoietic organs in vivo. Immunol. Lett. 33:9–14.
Piquet-Pellorce, C., F. Homo-Delarche, and M. Dy. 1989. Interleukin 1 and/or tumor necrosis factor-α synergize with granulocyte-macrophage colony-stimulating factor to enhance histamine synthesis in hematopoietic cells: role of prostaglandin E2. Eur. J. Immunol. 19:1999–2003.
Hirasawa, N., K. Ohuchi, M. Watanabe, and S. Tsurufuji. 1987. Role of endogenous histamine in postanaphylactic phase of allergic inflammation in rats. J. Pharmacol. Exp. Ther. 24 1:967–973.
Hirasawa, N., Y. Funaba, Y. Hirano, K. Kawarasaki, M. Omata, M. Watanabe, S. Mue, S. Tsurufuji, and K. Ohuchi. 1990. Inhibition by dexamethasone of histamine production in allergic inflammation in rats. J. Immunol. 145:3041–3046.
Hirasawa, N., K. Ohuchi, M. Watanabe, and S. Tsurufuji. 1987. Mechanism of the inhibitory action of cyclooxygenase inhibitors on leukocytes infiltration: involvement of endogenous histamine. Eur. J. Pharmacol. 144:267–275.
Ohuchi, K., N. Hirasawa, M. Watanabe, and S. Tsurufuji. 1985. Pharmacological analysis of the vascular permeability response in the anaphylactic phase of allergic inflammation. Eur. J. Pharmacol. 117:337–345.
Tsurufuji, S., S. Yoshino, and K. Ohuchi. 1982. Induction of an allergic air-pouch inflammation in rats. Int. Arch. Allergy Appl. Immunol. 69:189–198.
Shore, P. A., A. Burkhalter, and V. H. Cohn. 1959. A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182–186.
Watanabe, T., Y. Taguchi, K. Sasaki, K. Tsuyama, and Y. Kitamura. 1981. Increase in histidine decarboxylase activity in mouse skin after application of the tumor promotor tetradecanoylphorbol acetate. Biochem. Biophys. Res. Commun. 100:427–432.
Edamatsu, T., Y.-Q. Xiao, J. Tanabe, S. Mue, and K. Ohuchi. 1997. Induction of neutrophil chemotactic factor production by staurosporine in rat peritoneal neutrophils. Br. J. Pharmacol. 121:1651–1658.
Schneider, E., C. Piquet-Pellorce, and M. Dy. 1990. New role for histamine in interleukin-3-induced proliferation of hematopoietic stem cells. J. Cell. Physiol. 143:337–343.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirasawa, N., Shiraishi, M., Oikawa, S. et al. Increase in Histamine Production by Inflammatory Exudate in the Chronic Phase of Allergic Inflammation in Rats. Inflammation 22, 471–482 (1998). https://doi.org/10.1023/A:1022393926234
Issue Date:
DOI: https://doi.org/10.1023/A:1022393926234